Novartis’ oral therapy iptacopan shows promise in PNH
Majority of patients were transfusion-free through 12 weeks of study, according to the new data
Read More
Tag: EHA
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
